2026-14935NoticeWallet

Feds Fine Heart Valve Firms $12 Million Over Merger

Published Date: 7/23/2026

Notice

Summary

The U.S. government says Edwards LifeSciences broke the rules when it bought JC Medical from Genesis MedTech. Edwards must pay $10 million, Genesis pays $2 million, and Edwards has to get approval before buying any company working on special heart valve devices in the U.S. This keeps the market fair and protects competition in heart health tech.

Analyzed Economic Effects

5 provisions identified: 1 benefits, 4 costs, 0 mixed.

Company Civil Penalties Ordered

The court’s proposed Final Judgment orders Edwards to pay a civil penalty of $10,000,000 and Genesis to pay $2,000,000. Each company must pay the full penalty within thirty (30) days of entry of the Final Judgment, and interest of 18% per year will accrue on any late payment.

Edwards Must Notify Before TAVR-AR Deals

If you run a firm that sells or is conducting clinical trials in the United States for a transcatheter aortic valve replacement for aortic regurgitation (TAVR-AR) device, Edwards must give the Federal Trade Commission advance written Notification before acquiring any ownership interest in your firm. The Notification must use the Appendix to Part 803 Form, be filed with the FTC Secretary (no filing fee), and Edwards must wait at least thirty (30) days before closing (and wait an additional 30 days after any FTC request for more information).

Antitrust Compliance Program Required

Edwards must set up an antitrust compliance program: name an Antitrust Compliance Officer within thirty (30) days; distribute the Final Judgment to officers and key employees within forty-five (45) days; provide training within forty-five (45) days and annually thereafter; obtain written certifications within sixty (60) days and annually; and file annual compliance statements with the United States. The program also requires prompt internal action and reporting if violations are discovered.

DOJ Access and Inspection Rights

The United States may inspect Edwards' books, records, and documents relating to the Final Judgment during business hours and may interview Edwards' officers or employees (with counsel present if desired). Edwards must also supply written reports or interrogatory responses on request, subject to confidentiality rules (confidential designations expire after 10 years unless extended).

Judgment Intended to Protect Competition

The Competitive Impact Statement says the Final Judgment is intended to deter parties from structuring deals to avoid Hart-Scott-Rodino (HSR) review and that this relief will have a beneficial effect on competition. The United States explains that preventing HSR avoidance protects consumers and competition in the market for TAVR-AR devices.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
7/13/2026
7/23/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Antitrust Division
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register